Cancer cells have the ability to promote expansion of CD4 Tregs population, which in turn, due to FasL/CD95L expression, are able to stimulate apoptosis in effector T lymphocytes via CD95-dependent pathway [2]. This evidence concerns the gene FAS and cancer.